Norton Cancer Institute is a clinical research site located in Louisville, Kentucky, United States 40202.
Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.
Norton Cancer Institute has participated in 214 clinical trials with 82 currently active.
Therapeutic areas: Solid Tumor, Unresectable or Metastatic Melanoma, Gastric or Gastroesophageal Junction Adenocarcinoma.
Sponsors: CytomX Therapeutics, Phanes Therapeutics, Hoffmann-La Roche.
Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Norton Cancer Institute has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Norton Cancer Institute has 214 clinical trials on record, with 82 currently active. Their work covers Solid Tumor, Unresectable or Metastatic Melanoma, Gastric or Gastroesophageal Junction Adenocarcinoma.
Norton Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.